Why Insmed Inc (INSM) Stock Is Rising
As of 2026-08-07, Insmed Inc (INSM) has a next-year EPS growth estimate of 130.22%. Featured in our EPS revision report on 2026-08-07.
Why INSM Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Insmed Inc's next-year EPS growth estimate from 112.80% to 113.05% on 2026-07-31.
- →Estimate Trending Higher: Since detection, the estimate has moved up a net +17.17 pp to 130.22% across 2 upward revisions.
- !Largest Single-Day Revision: +14.59 pp on 2026-08-07 (115.63% → 130.22%).
- ·Current-Year Growth: Projected at 66.26%, supporting the forward estimate revision.
News Context
The primary structural driver is the EPS estimate upgrade, with analysts raising next-year growth expectations from 112.80% to 113.05% initially, and the estimate continuing to climb to 130.22% across subsequent revisions. The move is plausibly linked to Insmed's Q2 2026 earnings, which highlighted BRINSUPRI's 49% sequential revenue surge, prompted a raised revenue guidance, and expanded peak sales outlook. This momentum persisted beyond the first revision, as net EPS change reached +17.17 percentage points across two upward and one downward adjustment.
Generated 2026-08-07 · news as of 2026-08-07
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 130.22%
- EPS growth this year
- 66.26%
- EPS next quarter (est)
- -$0.50
- Last price
- $132.55
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-07 | 130.22% | 66.26% | -$0.50 | $132.55 |
| 2026-08-06 | 115.63% | 60.82% | -$0.58 | $132.55 |
| 2026-08-05 | 112.75% | 59.34% | -$0.69 | $99.02 |
| 2026-08-04 | 112.75% | 59.34% | -$0.69 | $98.75 |
| 2026-08-03 | 112.75% | 59.34% | -$0.69 | $98.45 |
| 2026-08-02 | 113.05% | 59.35% | -$0.69 | $98.60 |
| 2026-07-31 | 113.05% | 59.35% | -$0.69 | $98.60 |
| 2026-07-30 | 112.80% | 59.19% | -$0.70 | $101.49 |
| 2026-07-29 | 112.80% | 59.19% | -$0.70 | $103.12 |
| 2026-07-28 | 112.80% | 59.19% | -$0.70 | $104.13 |
| 2026-07-27 | 112.80% | 59.19% | -$0.70 | $104.73 |
| 2026-07-26 | 112.80% | 59.19% | -$0.70 | $106.92 |
| 2026-07-24 | 112.80% | 59.19% | -$0.70 | $106.92 |
| 2026-07-23 | 112.80% | 59.19% | -$0.70 | $107.41 |
| 2026-07-22 | 112.80% | 59.19% | -$0.70 | $106.64 |
| 2026-07-21 | 112.93% | 59.17% | -$0.70 | $108.62 |
| 2026-07-20 | 112.83% | 59.18% | -$0.70 | $107.02 |
| 2026-07-19 | 112.83% | 59.18% | -$0.70 | $108.32 |
| 2026-07-17 | 112.83% | 59.18% | -$0.70 | $108.32 |
| 2026-07-16 | 112.83% | 59.18% | -$0.70 | $107.46 |
| 2026-07-15 | 115.46% | 58.53% | -$0.71 | $109.81 |
| 2026-07-14 | 115.14% | 58.56% | -$0.71 | $110.11 |
| 2026-07-13 | 115.14% | 58.56% | -$0.71 | $109.14 |
| 2026-07-12 | 112.67% | 58.34% | -$0.71 | $115.61 |
| 2026-07-09 | 112.60% | 57.84% | -$0.75 | $118.26 |
| 2026-07-08 | 112.60% | 57.84% | -$0.75 | $116.53 |
| 2026-07-07 | 112.61% | 57.84% | -$0.75 | $112.84 |
| 2026-07-06 | 113.09% | 57.89% | -$0.75 | $111.54 |
| 2026-07-05 | 113.09% | 57.89% | -$0.75 | $111.60 |
| 2026-07-02 | 113.09% | 57.89% | -$0.75 | $111.60 |
Reports Featuring INSM
Recent News
- Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ...GuruFocus.com
- Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ...GuruFocus.com
- Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales OutlookInvestorsHub
- Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales OutlookInvestorsHub
- Insmed: Q2 Earnings SnapshotAssociated Press
- Insmed: Q2 Earnings SnapshotAssociated Press
- Insmed Reports Second-Quarter 2026 Financial Results and Provides Business UpdatePR Newswire
- Insmed Reports Second-Quarter 2026 Financial Results and Provides Business UpdatePR Newswire
- Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global RespiratoryPR Newswire
- Nasdaq-100 Adds New AI and Space Winners. These Stocks Are SoaringGuruFocus.com
Screen Performance
Aggregate stats across all 1928 tickers our top-EPS-revision screen has flagged over the past 128 days.
- Median return since detection
- +3.1%
- % of tickers in the green
- 56%
- Median return on winners
- +20.6%
- Large revisions captured
- 1312
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Insmed Inc (INSM) stock go up recently?▾
Insmed Inc (INSM) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 112.80% to 113.05% on 2026-07-31. Since detection, the estimate has moved up a net +17.17 pp to 130.22%. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Insmed Inc's next-year EPS growth estimate?▾
As of 2026-08-07, Insmed Inc (INSM) has a next-year EPS growth estimate of 130.22%, based on analyst consensus.
When was the latest EPS estimate revision for INSM?▾
The most recent revision occurred on 2026-08-07, when analysts adjusted the next-year EPS growth estimate from 115.63% to 130.22%.
What sector and industry does Insmed Inc belong to?▾
Insmed Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. INSM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Insmed Inc (INSM) appears here because it was detected by our daily top-EPS-revision-performer screen.